Sigma Healthcare (ASX:SIG) said that growth in its normalized earnings before taxes and interest (EBIT) for the nine months to March 31 was broadly consistent with Chemist Warehouse Group's reported 36% increase in normalized EBIT in the fiscal first half, according to a Tuesday Australian bourse filing.

Chemist Warehouse Group's normalized EBIT for the first half of fiscal 2025 came in at AU$446.1 million, compared with the AU$328.4 million reported in the prior-year period.

The company said it incurred transaction costs of AU$42.4 million up to March 31, with AU$8.1 million incurred in the first half of fiscal 2025 and AU$34.3 million incurred in the third quarter.

Sigma Healthcare's shares fell almost 6% in recent Tuesday trade.